| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $291.8M | $247.2M | $221.6M |
| YoY Revenue Growth % | +18.0% | +11.6% | — |
| Gross Profit | $51.6M | $45.8M | — |
| Gross Margin % | 17.7% | 18.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$513.0K | -$8.1M | -$18.8M |
| Operating Margin % | -0.2% | -3.3% | -8.5% |
| Net Income (GAAP) | $1.4M | -$25.9M | -$36.7M |
| EBITDA (Normalized) | -$485.8K | -$8.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$11.9M | -$32.6M | -$17.4M |
| Capital Expenditures (CapEx) | $34.0K | $54.0K | — |
| Free Cash Flow (FCF) | -$12.0M | -$32.6M | -$17.4M |
| FCF Margin % | -4.1% | -13.2% | -7.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $22.4M | $3.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$38.1M | -$46.8M | — |